HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PTPRT
protein tyrosine phosphatase receptor type T
Chromosome 20 Β· 20q12-q13.11
NCBI Gene: 11122Ensembl: ENSG00000196090.14HGNC: HGNC:9682UniProt: A0A075B6H0
50PubMed Papers
20Diseases
0Drugs
6Pathogenic Variants
FUNCTIONAL ROLE
Receptor
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein tyrosine phosphatase activitytransmembrane receptor protein tyrosine phosphatase activityprotein bindingbeta-catenin bindingalcohol drinkingmelanomagastric carcinomaprostate carcinoma
✦AI Summary

PTPRT (protein tyrosine phosphatase receptor type T) is a brain-specific transmembrane protein that functions as a receptor-type tyrosine phosphatase with critical roles in neuronal development and cancer biology. In the nervous system, PTPRT regulates synaptic formation and neuronal development by forming homophilic trans dimers and heterophilic cis complexes with neuronal adhesion molecules 1. The protein dephosphorylates key substrates including BCR-Rac1 GAP and Syntaxin-binding protein, thereby controlling actin cytoskeleton polymerization and neurotransmitter release 1. PTPRT undergoes ADAM10- and Ξ³-secretase-dependent cleavage, releasing an intracellular domain that translocates to the nucleus and regulates gene expression related to synapse formation and cell adhesion 2. In cancer, PTPRT functions as a tumor suppressor that is frequently mutated or downregulated across multiple cancer types 34. Loss of PTPRT enhances cancer cell proliferation, migration, and invasion through upregulation of survivin and other cell cycle-related genes 3. Paradoxically, PTPRT mutations predict enhanced response to immune checkpoint inhibitors by activating the STING pathway through prevention of STING proteasome degradation, leading to increased immune cell infiltration 54. PTPRT mutations are associated with cancer metastasis and serve as potential biomarkers for both prognosis and immunotherapy response 6.

Sources cited
1
PTPRT regulates synaptic formation and neuronal development through homophilic trans dimers and dephosphorylation of BCR-Rac1 GAP and Syntaxin-binding protein
PMID: 25748173
2
PTPRT undergoes ADAM10- and Ξ³-secretase-dependent cleavage releasing an intracellular domain that translocates to the nucleus
PMID: 36583697
3
PTPRT downregulation enhances cancer cell proliferation, migration, and invasion through upregulation of survivin
PMID: 38216925
4
PTPRT loss enhances immune checkpoint inhibitor response by activating the STING pathway and preventing STING degradation
PMID: 39231239
5
PTPRT mutations predict enhanced response to immune checkpoint inhibitors in melanoma and NSCLC
PMID: 34862763
6
PTPRT mutations are associated with cancer metastasis and serve as potential biomarkers
PMID: 35789644
Disease Associationsβ“˜20
alcohol drinkingOpen Targets
0.48Moderate
melanomaOpen Targets
0.41Moderate
gastric carcinomaOpen Targets
0.37Weak
prostate carcinomaOpen Targets
0.37Weak
esophageal adenocarcinomaOpen Targets
0.37Weak
cutaneous melanomaOpen Targets
0.37Weak
bile duct carcinomaOpen Targets
0.37Weak
breast ductal adenocarcinomaOpen Targets
0.37Weak
carcinoma of liver and intrahepatic biliary tractOpen Targets
0.37Weak
HER2 Positive Breast CarcinomaOpen Targets
0.37Weak
lung carcinomaOpen Targets
0.37Weak
lymphoid neoplasmOpen Targets
0.37Weak
nodular melanomaOpen Targets
0.37Weak
pancreatic ductal adenocarcinomaOpen Targets
0.37Weak
pancreatic neuroendocrine tumorOpen Targets
0.37Weak
papillary thyroid carcinomaOpen Targets
0.37Weak
prostate adenocarcinomaOpen Targets
0.37Weak
skin carcinomaOpen Targets
0.37Weak
skin squamous cell carcinomaOpen Targets
0.37Weak
Uterine CarcinosarcomaOpen Targets
0.37Weak
Pathogenic Variants6
NC_000020.11:g.(?_42232174)_(42274201_?)delLikely pathogenic
Schizophrenia
β˜…β˜†β˜†β˜†2018
NC_000020.11:g.(?_42303583)_(42488707_?)delLikely pathogenic
Autism
β˜…β˜†β˜†β˜†2018
NC_000020.11:g.(?_42461895)_(42648116_?)delLikely pathogenic
Autism
β˜…β˜†β˜†β˜†2018
NC_000020.11:g.(?_42472130)_(42562200_?)delLikely pathogenic
Schizophrenia
β˜…β˜†β˜†β˜†2018
NM_007050.6(PTPRT):c.1561-3C>TLikely pathogenic
Abnormal brain morphology
β˜…β˜†β˜†β˜†
NM_007050.6(PTPRT):c.206T>C (p.Val69Ala)Likely pathogenic
Abnormal brain morphology
β˜…β˜†β˜†β˜†β†’ Residue 69
View on ClinVar β†—
Related Genes
PTSProtein interaction73%PTPRUShared pathway29%CDHR4Shared pathway29%PCDH11YShared pathway29%PCDH20Shared pathway29%PCDH19Shared pathway29%
Tissue Expression6 tissues
Brain
100%
Heart
2%
Liver
1%
Lung
1%
Ovary
0%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
PTPRTPTSPTPRUCDHR4PCDH11YPCDH20PCDH19
PROTEIN STRUCTURE
Preparing viewer…
PDB2OOQ Β· 1.80 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.40Moderately Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.31 [0.25–0.40]
RankingsWhere PTPRT stands among ~20K protein-coding genes
  • #8,864of 20,598
    Most Researched50
  • #3,397of 5,498
    Most Pathogenic Variants6
  • #1,956of 17,882
    Most Constrained (LOEUF)0.40 Β· top quartile
Genes detectedPTPRT
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PTPRT loss enhances anti-PD-1 therapy efficacy by regulation of STING pathway in non-small cell lung cancer.
PMID: 39231239
Sci Transl Med Β· 2024
1.00
2
Single-nucleus RNA sequencing of human pancreatic islets identifies novel gene sets and distinguishes Ξ²-cell subpopulations with dynamic transcriptome profiles.
PMID: 37127706
Genome Med Β· 2023
0.90
3
Protein tyrosine phosphatase PTPRT as a regulator of synaptic formation and neuronal development.
PMID: 25748173
BMB Rep Β· 2015
0.80
4
PTPRT Could Be a Treatment Predictive and Prognostic Biomarker for Breast Cancer.
PMID: 34414233
Biomed Res Int Β· 2021
0.70
5
Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma.
PMID: 38216925
BMC Cancer Β· 2024
0.60